Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial Comment

被引：0

作者：

Mendoza, Manel ^{[1
]}

Bonacina, Erika ^{[1
]}

Garcia-Manau, Pablo ^{[1
]}

Lopez, Monica ^{[2
]}

Caamina, Sara ^{[3
]}

Vives, Angels ^{[4
]}

Lopez-Quesada, Eva ^{[5
]}

Ricart, Marta ^{[6
]}

Maroto, Anna ^{[7
]}

de Mingo, Laura ^{[2
,8
]}

Pintado, Elena ^{[9
]}

Ferrer-Costa, Roser ^{[10
]}

Martin, Lourdes

Rodriguez-Zurita, Alicia ^{[3
]}

Garcia, Esperanza ^{[4
]}

Pallarols, Mar ^{[5
]}

Vidal-Sagnier, Laia ^{[6
]}

Teixidor, Mireia ^{[7
]}

Orizales-Lago, Carmen ^{[8
]}

Perez-Gomez, Adela ^{[3
]}

Ocana, Vanesa ^{[9
]}

Puerto, Linda ^{[2
]}

Millan, Pilar ^{[4
]}

Alsius, Merce ^{[11
]}

Diaz, Sonia ^{[9
]}

Maiz, Nerea ^{[1
]}

Carreras, Elena ^{[1
]}

Suy, Anna ^{[1
]}

机构：

[1] Univ Autonoma Barcelona, Vall dHebron Barcelona Hosp Campus, Dept Obstet, Maternal Fetal Med Unit, Barcelona, Spain

[2] Hosp Univ Tarragona Joan XXIII, Dept Obstet, Tarragona, Spain

[3] Hosp Univ Nuestra Senora Candelaria, Dept Obstet, St Cruzde De Tenerife, Spain

[4] Consorci Sanit Terrassa, Dept Obstet, Terrassa, Spain

[5] Hosp Univ Mutua Terrassa, Dept Obstet, Terrassa, Spain

[6] Hosp Univ Germans Trias i Pujol, Dept Obstet, Badalona, Spain

[7] Hosp Univ Girona Doctor Josep Trueta, Dept Obstet, Girona, Spain

[8] Hosp Univ Severo Ochoa, Dept Obstet, Leganes, Spain

[9] Hosp Univ Getafe, Dept Obstet, Getafe, Spain

[10] Vall dHebron Barcelona Hosp Campus, Dept Biochem, Barcelona, Spain

[11] Hosp Univ Girona Doctor Josep Trueta, Dept Biochem, Girona, Spain

来源：

OBSTETRICAL & GYNECOLOGICAL SURVEY | 2023年 / 78卷 / 08期

关键词：

D O I：

10.1097/OGX.0000000000001186

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：449 / 451

页数：3

共 50 条

[1] Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia A Randomized Clinical Trial
Mendoza, Manel
Bonacina, Erika
Garcia-Manau, Pablo
Lopez, Monica
Caamina, Sara
Vives, Angels
Lopez-Quesada, Eva
Ricart, Marta
Maroto, Anna
de Mingo, Laura
Pintado, Elena
Ferrer-Costa, Roser
Martin, Lourdes
Rodriguez-Zurita, Alicia
Garcia, Esperanza
Pallarols, Mar
Vidal-Sagnier, Laia
Teixidor, Mireia
Orizales-Lago, Carmen
Perez-Gomez, Adela
Ocana, Vanesa
Puerto, Linda
Millan, Pilar
Alsius, Merce
Diaz, Sonia
Maiz, Nerea
Carreras, Elena
Suy, Anna
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (07): : 542 - 550
[2] Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial
Ricart, Marta
Bonacina, Erika
Garcia-Manau, Pablo
Lopez, Monica
Caamina, Sara
Vives, Angels
Lopez-Quesada, Eva
Maroto, Anna
de Mingo, Laura
Pintado, Elena
Ferrer-Costa, Roser
Martin, Lourdes
Rodriguez-Zurita, Alicia
Garcia, Esperanza
Pallarols, Mar
Pratcorona, Laia
Teixidor, Mireia
Orizales-Lago, Carmen
Ocana, Vanesa
del Barco, Esther
Carreras, Elena
Suy, Anna
Mendoza, Manel
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2024, 103 (11) : 2273 - 2280
[3] Aspirin Discontinuation in Pregnancies at High Risk of Preterm Preeclampsia
Parchem, Jacqueline G.
Sibai, Baha M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (22): : 1987 - +
[4] Aspirin Discontinuation in Pregnancies at High Risk of Preterm Preeclampsia In Reply
Mendoza, Manel
Carreras, Elena
Suy, Anna
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (22): : 1988 - 1989
[5] Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, Daniel L.
Wright, David
Poon, Liona C.
O'Gorman, Neil
Syngelaki, Argyro
de Paco Matallana, Catalina
Akolekar, Ranjit
Cicero, Simona
Janga, Deepa
Singh, Mandeep
Molina, Francisca S.
Persico, Nicola
Jani, Jacques C.
Plasencia, Walter
Papaioannou, George
Tenenbaum-Gavish, Kinneret
Meiri, Hamutal
Gizurarson, Sveinbjorn
Maclagan, Kate
Nicolaides, Kypros H.
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2018, 73 (01) : 11 - 12
[6] Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, Daniel L.
Wright, David
Poon, Liona C.
O'Gorman, Neil
Syngelaki, Argyro
de Paco Matallana, Catalina
Akolekar, Ranjit
Cicero, Simona
Janga, Deepa
Singh, Mandeep
Molina, Francisca S.
Persico, Nicola
Jani, Jacques C.
Plasencia, Walter
Papaioannou, George
Tenenbaum-Gavish, Kinneret
Meiri, Hamutal
Gizurarson, Sveinbjorn
Maclagan, Kate
Nicolaides, Kypros H.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07): : 613 - 622
[7] Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Sentilhes, Loic
Azria, Elie
Schmitz, Thomas
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (24): : 2399 - 2400
[8] Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia REPLY
Nicolaides, Kypros H.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (24): : 2400 - 2400
[9] AGGRESSIVE VERSUS EXPECTANT MANAGEMENT OF SEVERE PREECLAMPSIA AT 28 TO 32 WEEKS GESTATION - A RANDOMIZED CONTROLLED TRIAL
SIBAI, BM
MERCER, BM
SCHIFF, E
FRIEDMAN, SA
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (03) : 818 - 822
[10] AGGRESSIVE OR EXPECTANT MANAGEMENT FOR PATIENTS WITH SEVERE PREECLAMPSIA BETWEEN 28-34 WEEKS GESTATION - A RANDOMIZED CONTROLLED TRIAL
ODENDAAL, HJ
PATTINSON, RC
BAM, R
GROVE, D
KOTZE, TJV
OBSTETRICS AND GYNECOLOGY, 1990, 76 (06): : 1070 - 1075

← 1 2 3 4 5 →